Safety, Tolerability and PK/PD of JMT103 in Patients With Bone Metastases From Tumors
Clinical trial NCT03550508 · UNKNOWN
Trial details
- NCT number
- NCT03550508
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2019-08-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.